Remote patient monitoring compliance is the question of whether a company that holds continuous, intimate data about your body can prove — not promise — that it protects that data through every change of management, every change of supplier, and every release that ships after the marketing page was written. Most cannot. And in 2026 the federal rule that was supposed to force the issue has been pushed to the far side of the calendar, which means the people deciding who is trustworthy are no longer regulators. They are buyers, health systems, and patients reading terms of service.
Here is a personal position on remote patient monitoring compliance, stated plainly, from someone who has spent 28 years inside management systems: I would not hand my medical monitoring data to a company that has not demonstrated the rigor of a certified information security management system. Not because certification is magic. Because after 200+ certification audits, I have watched what happens to excellent controls when the person who built them leaves, when the analytics vendor changes, when a new executive arrives with new priorities. Controls decay quietly. A management system is the thing that notices.
Direct Answer
Remote patient monitoring compliance is the set of documented, auditable practices that prove a connected health product handles patient data lawfully, securely, and consistently over time. It spans device regulation where the product is a regulated device, HIPAA obligations where a covered entity or business associate relationship exists, and information security management everywhere else. Because the HIPAA Security Rule overhaul has been delayed and consumer wearables often sit outside HIPAA entirely, remote patient monitoring compliance is increasingly demonstrated through certified management systems and evidence a buyer can inspect — not through policy language a buyer is asked to trust.
The Regulatory Vacuum
What Does Remote Patient Monitoring Compliance Require When the Regulator Steps Back?
Delayed. Not dead. Still enforceable.
The federal baseline for remote patient monitoring compliance was supposed to change. In December 2024 the Office for Civil Rights at the U.S. Department of Health and Human Services issued a Notice of Proposed Rulemaking to modernize the HIPAA Security Rule — the first substantial overhaul in more than two decades. It was published in the Federal Register on January 6, 2025, and the comment period closed on March 7, 2025. The proposal would remove the long-standing distinction between required and addressable implementation specifications, mandate multi-factor authentication and encryption, require comprehensive asset inventories and network mapping, impose annual penetration testing, and substantially strengthen oversight of business associates. HHS estimated first-year industry costs near $9 billion. The OCR fact sheet lays out the proposed structure in full.
Then it stalled. A coalition of more than 100 hospital systems and provider associations asked the Department to withdraw or substantially narrow the rule. The target for final action slipped from May 2026, and the proposal has now been moved to the long-term actions agenda with an anticipated timeframe of July 2027. Unified Agenda dates are planning estimates rather than binding deadlines, and placement on the long-term list generally signals that no final rule is expected within twelve months. The practical effect on remote patient monitoring compliance is a gap of at least a year, and probably longer, between what regulators say good security looks like and what regulators actually require.
Two things follow, and organizations that confuse them will make expensive mistakes. First, the existing HIPAA Security Rule remains fully in force and fully enforceable. OCR has publicly expanded its enforcement initiative beyond risk analysis to risk management — meaning the agency is asking not only whether you identified risks but what you did about them. Nothing about the delay lowers the floor. Second, the delay does not pause the market. Health systems, payers, employers, and device manufacturers are still buying connected monitoring, still running vendor security reviews, and still deciding who to trust. Remote patient monitoring compliance is being adjudicated right now — just in procurement rather than in enforcement.
Direct Answer
The proposed HIPAA Security Rule overhaul is not final. It was published as an NPRM on January 6, 2025, and final action has been moved to a long-term agenda targeting July 2027. The existing Security Rule remains fully enforceable, and OCR enforcement has expanded from risk analysis to risk management. For connected health vendors, remote patient monitoring compliance therefore rests on the current rule plus whatever evidence buyers demand — and buyers are demanding more than regulators currently require. Treat the delay as runway to build, not permission to wait.
Two Case Files
What Flo and Oura Reveal About Remote Patient Monitoring Compliance
One enforcement file. One terms page.
Abstract arguments about remote patient monitoring compliance persuade nobody, and buyers have heard all of them. Two public records do the work better than any framework diagram. The first is a documented enforcement action and a jury verdict. The second is simply a company's own published pages, read carefully. Neither is an accusation. Both are matters of record.
Flo: when the policy was true and the system was not
Flo is a period and fertility tracking app used by more than 100 million people. Users tell it when their period started, when they are trying to conceive, when they are pregnant, and what symptoms they are experiencing. That is not general health data. That is the most sensitive category of information a person can enter into a phone, volunteered daily, by women who believed the app when it said the information would stay private.
The Federal Trade Commission alleged that despite promising to keep users' health data private, Flo Health shared sensitive health information from millions of users of its period and ovulation tracking app with marketing and analytics firms including Facebook and Google. Press analysis at the time found no available means for users to prevent that information from reaching Facebook. The proposed settlement and the finalized order require affirmative consent before sharing personal health information, an independent review of privacy practices, notification of affected users, and instructions to third parties to destroy the data they received. The full docket sits in the FTC's case library, and the Commission's reasoning on the notice requirement is set out in the analysis of the proposed consent order.
The story did not end with the settlement, which is the part most remote patient monitoring compliance discussions miss. On August 1, 2025, a unanimous San Francisco jury found Meta Platforms liable under the California Invasion of Privacy Act for capturing ovulation and menstrual information communicated through the app by way of an embedded software development kit. Google and Flurry settled before trial; Flo settled during trial. The related class settlements total $59.5 million, with a claim deadline of October 15, 2026 and a settlement hearing scheduled for October 29, 2026.
Now the detail that should stop every quality professional in their tracks. The jury was asked a simple question — did the company have consent to record — and answered no. Commentators reading the verdict concluded the terms of use were likely too long, too esoteric, and too difficult to read to function as consent at all. A document existed. A promise existed. What did not exist was a mechanism ensuring the promise stayed true at the code level, release after release, vendor after vendor.
That is not a privacy failure. It is a document control failure, a supplier control failure, and a change control failure wearing a privacy headline. Every ISO auditor has seen this exact shape before.
Oura: read the terms, then decide
The second case is not a failure at all, which is precisely why it teaches more. Oura makes a beautifully designed ring that collects one of the largest continuous biometric datasets in consumer health — heart rate, heart rate variability, skin temperature, blood oxygen, respiratory rate, sleep staging, activity, and, for members who opt in, menstrual cycle information. The company invests visibly in security and publishes more than most of its category. That is the point of using it as an example.
Read its Security Center and you will find the audits and validations it names: an annual independent SOC 2 Type II audit of security controls, a third-party HIPAA audit supporting compliance efforts, penetration testing, and vulnerability scanning, alongside TLS 1.2+ in transit and AES-256 at rest. What that page does not name is certification to a management system standard for information security. Third-party software directories describe the company as “ISO 27001 compliant,” but compliant is a word a company can write about itself. Certified is a word an accredited certification body writes about you, after an audit, with surveillance to follow.
Then read the privacy policy, which is admirably direct about something most consumers never consider. Oura states that it is generally not a Covered Entity under HIPAA for its direct-to-consumer services. And when you direct a HIPAA-regulated entity to disclose your health records to Oura, the policy explains that the disclosure is made at your request rather than the entity's, that Oura is not acting as a Business Associate for that sharing, and that the records no longer fall under HIPAA while in Oura's possession.
“Your medical records lose their federal protection the moment they arrive. That is not hidden and it is not wrongdoing — it is disclosed, in plain language, in a document almost nobody reads. Remote patient monitoring compliance begins with understanding that the protection you assume you have may end at the vendor's front door.” — Diana Lynn, President, Management Systems International
Set the two cases side by side and the lesson for remote patient monitoring compliance is not that one company is bad and another is good. It is that a well-resourced, transparent, security-serious operator still stops at attestation and still tells you where legal protection ends — while a company that made confident privacy promises without a system behind them ended up in an enforcement order and a courtroom. If that is the range at the top of the category, the median vendor deserves harder questions than most buyers are asking.
Direct Answer
Two public records frame remote patient monitoring compliance better than any framework. The FTC alleged Flo Health shared sensitive health data with analytics and marketing firms despite privacy promises, and a 2025 jury later found Meta liable under California's Invasion of Privacy Act for capturing that data through an embedded SDK. Separately, Oura's own published pages name SOC 2 Type II and a third-party HIPAA audit rather than management system certification, and disclose that records you direct into the service no longer fall under HIPAA. Effective remote patient monitoring compliance means reading what a vendor actually publishes rather than what a marketing page implies.
The Real Distinction
Attestation or Certification: The Choice That Decides Remote Patient Monitoring Compliance
Controls tested. Systems certified.
This is the distinction the market blurs, the one that decides remote patient monitoring compliance, and the one management systems professionals cannot afford to lose. An attestation report tells you that an auditor tested a set of controls the organization itself selected, over a window of time that has already closed. It is a photograph. A useful, expensive, skillfully taken photograph — and a photograph nonetheless.
A certified management system is different in kind, not degree, and that difference is what remote patient monitoring compliance ultimately rests on. ISO/IEC 27001 requires a defined scope, a documented risk assessment and risk treatment plan, and a Statement of Applicability in which every control is either applied with justification or excluded with justification. It requires defined competence, documented information under control, internal audit at planned intervals, management review by top management, and corrective action when something fails. The 2022 edition restructured its reference controls into four themes and reduced them from 114 to 93, with supplier relationships addressed across controls 5.19 through 5.22 and cloud services addressed at 5.23 — the two areas where connected health products leak most. Implementation guidance sits in ISO/IEC 27002. Certificates are issued by accredited bodies and maintained through annual surveillance, which means the system is examined again next year whether or not anyone remembers to care.
Why does that matter for remote patient monitoring compliance specifically? Because the risk in connected health is not a single bad decision. It is drift. A capable security lead departs. An analytics vendor is swapped during a cost review. A growth team adds an SDK to measure onboarding. A cloud region changes. None of those events is malicious and none is unusual, and every one of them can quietly break a promise printed on a website two years earlier. Attestation proves the controls held during the window. Certification proves there is a mechanism designed to notice when they stop holding. Diana's position — that she would not trust a company lacking that rigor even through a change of management or suppliers — is not a preference. It is the failure mode, named precisely.
A necessary and honest boundary: Management Systems International does not implement ISO/IEC 27001, and this article is not a pitch for it. MSI implements ISO 9001, ISO 13485, ISO 14001, and ISO 45001, with an expanding focus on ISO 7101 healthcare quality. What 28 years of building those systems provides is the architecture into which an information security management system plugs — the shared harmonized clause structure, the audit discipline, the document and change control that make any standard survive contact with reality. We have written about how that layering works at scale in our guide to multi-site ISO integration, and about why different standards keep different clause architectures in the ISO consulting decoder ring.
Direct Answer
An attestation report confirms that selected controls were tested over a closed window. A management system certification confirms an organization operates a scoped, risk-driven system with a Statement of Applicability, defined competence, internal audit, management review, corrective action, and annual surveillance. For remote patient monitoring compliance, that difference matters because the dominant risk is drift — staff turnover, vendor substitution, new SDKs, changed cloud services. Attestation shows the controls held; certification shows a mechanism exists to detect when they stop. Strong remote patient monitoring compliance asks for both.
The Clause Map
Where Remote Patient Monitoring Compliance Lives in Your ISO 13485 Quality System
Map it. Own it. Prove it.
If your monitoring product is a regulated device, remote patient monitoring compliance is already quality system work whether or not anyone has said so out loud. The Quality Management System Regulation took effect on February 2, 2026, amending 21 CFR Part 820 and incorporating ISO 13485:2016 by reference, as published at 89 FR 7496. One day later the FDA reissued its cybersecurity guidance so the citations would match. We unpacked that shift in detail in our analysis of medical device cybersecurity as a quality system obligation and in our breakdown of the FDA QMSR rule.
Scope note. Not every monitoring product is a regulated device. The FDA's General Wellness policy for low risk devices signals where enforcement discretion applies, and a single feature release can move a product across that line. Our companion guide to digital health FDA compliance works through the boundary in detail. Determine which side you are on before you design the evidence.
For regulated monitoring devices, here is the mapping MSI builds with device clients. It is not the only defensible map, but it is one that has survived contact with auditors — and having a map at all is what separates an organization that can answer an investigator from one that improvises.
Clause 4.2.3 — Medical Device File. Data flow diagrams, the security architecture description, the software bill of materials, retention schedules, and privacy-relevant labeling all belong in the documented device file. This is the folder an investigator opens first.
Clause 6.2 — Competence. Who is qualified to review a data processing agreement, triage a disclosed vulnerability, or approve an SDK? Competence is defined per role and evidenced. A contractor's résumé in an email thread is not evidence.
Clause 7.1 — Planning of Product Realization. Where the risk process is declared and connected to ISO 14971, so that a data-handling risk becomes an evaluated, controlled risk of patient harm rather than a backlog ticket.
Clause 7.3 — Design and Development. Consent mechanics, telemetry scope, and data minimization enter as design inputs, are examined at design review, proven at verification, confirmed at validation, and governed through change control. Consent designed at the end is consent litigated later. Our guide to the design and development process covers the discipline.
Clause 7.4 — Purchasing. Analytics providers, SDK vendors, and cloud processors are purchased product in every sense that matters. This is the clause Flo's story lives in. Supplier evaluation, re-evaluation on change, and records of both. See also our piece on ISO certified suppliers.
Clause 8.2 — Feedback and Complaint Handling. A privacy complaint or a reported vulnerability is feedback, sometimes a complaint, and sometimes a reportable event. Your intake process must tell the difference and prove it did.
Clause 8.5 — Corrective and Preventive Action. Removing an over-collecting SDK is a correction. Changing the process so no SDK ships unreviewed is the corrective action. Confusing the two is the most common finding MSI sees, as covered in our guide to CAPA under ISO 13485.
Build Clause 7.4 This Week
The Purchasing and Supplier Procedure Template — Because 7.4 Is Where Remote Patient Monitoring Compliance Actually Breaks
Every failure in this article traces back to the same clause. The analytics provider nobody re-evaluated. The SDK that arrived with a feature. The sub-processor that changed hands during an acquisition and never triggered a review. Clause 7.4 is not paperwork — it is the control that decides whether a change of suppliers quietly rewrites what your product does with patient data.
MSI's Purchasing and Supplier Procedure Template and Guide gives you the whole control, written to be used rather than filed: supplier evaluation and selection criteria, approved supplier list structure, re-evaluation triggers including change of ownership and change of sub-processor, purchasing information requirements, verification of purchased product, and the records that prove each step happened. Written by a consultant who has attended 200+ certification audits and watched exactly which supplier records auditors pull first.
Get the Purchasing and Supplier Procedure Template → · Editable, clause-mapped, and ready to adapt to your supplier base today. Questions about fit? Call 760-434-9141.
Note what ISO 13485 is not. It is a pre-Annex SL standard with its own clause architecture, and it does not contain an information security management system. That is exactly why remote patient monitoring compliance in a device company requires two systems that talk to each other rather than one system asked to do a job it was never written for. Background on the standard itself sits on our ISO 13485 medical device standard page and in our overview of what the ISO 13485 standard covers.
Direct Answer
In a regulated device organization, remote patient monitoring compliance maps to ISO 13485 as follows: data flow and architecture documentation into the Medical Device File (4.2.3), qualified reviewers into competence (6.2), the risk process into realization planning (7.1) linked to ISO 14971, consent and telemetry decisions into design and development (7.3), analytics and cloud vendors into purchasing (7.4), privacy complaints and vulnerability reports into feedback (8.2), and fixes plus process changes into CAPA (8.5). Because ISO 13485 contains no information security management system, complete remote patient monitoring compliance requires the two systems to interlock deliberately.
For The Buyer
How Should a Health System Evaluate Remote Patient Monitoring Compliance in a Vendor?
Ask for evidence. Not adjectives.
Hospitals, clinics, and health systems are now the effective regulators of remote patient monitoring compliance, and most vendor questionnaires are not built for the job. They collect adjectives. What they need is evidence. Nine questions separate a vendor with a system from a vendor with a policy, and every one of them can be answered in a single meeting by an organization that has done the work.
1. What is the certified scope? Not whether a certificate exists — which entities, which sites, which services it covers, and where the boundary sits. A certificate covering a corporate function while the monitoring platform sits outside scope tells you almost nothing.
2. Who accredited the certification body? Certification is only as meaningful as the accreditation behind it, and accreditation arrangements have changed in 2026 with the establishment of Global ACI. Ask, and verify.
3. May we see the Statement of Applicability? Excluded controls, with justifications, tell you more about a vendor's real posture than the entire marketing site.
4. When was the last management review, and what did it decide? You are not asking for minutes. You are asking whether leadership looks at this at planned intervals or whether it lives entirely in engineering.
5. Show the last three internal audit findings and their closure evidence. A vendor with no findings has an audit program that is not working.
6. What is your process when a supplier changes? This is the drift question, and it is the one that most often produces silence.
7. What third-party code runs in the patient-facing application, and who approved it? The Flo record makes this the single highest-value question on the list.
8. Where does HIPAA protection begin and end in this arrangement? Ask the vendor to state it plainly in writing and compare the answer to their published policy.
9. Who owns the seam? Name the individual accountable for the boundary between security activity and quality evidence. If nobody owns it, nobody is doing it.
Health systems pursuing their own management system maturity find these remote patient monitoring compliance questions easier to ask because they have answered them internally. That is one of the underrated returns of ISO 7101 healthcare quality management — an organization that runs planned management review and internal audit knows exactly what those artifacts look like when they are real, and recognizes immediately when they are not. Our work on healthcare digital transformation and on multi-site ISO certification covers the provider-side architecture.
Direct Answer
To evaluate remote patient monitoring compliance in a vendor, ask for the certified scope, the accrediting body, the Statement of Applicability, the date and decisions of the last management review, the last three internal audit findings with closure evidence, the process followed when a supplier changes, an inventory of third-party code in the patient-facing application with approval records, a written statement of where HIPAA protection begins and ends, and the name of the person accountable for the seam between security work and quality evidence. Vendors with real remote patient monitoring compliance answer all nine in one meeting.
From 200+ Audits
How Remote Patient Monitoring Compliance Actually Fails in the Audit Room
Observed. Repeated. Preventable.
Across 28 years and 200+ certification audits attended alongside clients, MSI has watched the same failure modes repeat every time a technical discipline meets a quality auditor for the first time. Remote patient monitoring compliance is following the pattern software validation followed a decade ago, and design controls followed before that. The technology is new. The failure is not. MSI client experience suggests these are the patterns most likely to produce a finding.
The privacy policy nobody traced to a process
A well-written public commitment with no procedure requiring anyone to keep it true. Ask which document controls the promise and who reviews it when the product changes. Silence here is the Flo failure in miniature, before the consequences arrive.
The supplier who was evaluated once
Approved at onboarding in 2022, never re-evaluated through two acquisitions and a change of sub-processor. Under Clause 7.4 that is a records failure and a control failure at once — and it is the precise scenario where a change of suppliers quietly rewrites what your product does with patient data.
The consent flow that was a design decision nobody documented
Someone chose what the checkbox says and when it fires. If that choice never entered design input, never appeared at design review, and never underwent verification, there is no record explaining why it is adequate. The Frasco jury's answer suggests how that gap reads to people outside the company.
The management review that never mentions data
Every required input covered; privacy incidents, vendor changes, and security posture absent, because nobody added them. Under the QMSR those minutes are inspectable, and their silence is itself a data point. Our ISO 13485 management review playbook walks through what a defensible review contains.
The system that decayed between surveillance visits
Certified once, then left alone. Organizations typically report that the erosion is invisible until an audit or an incident exposes it. We catalogued the pattern in five ISO maintenance risks certified companies overlook, and it is the reason maturity measurement matters — see our look at the FDA Voluntary Improvement Program.
The startup that assumed the standard did not apply yet
Remote patient monitoring compliance is cheapest when built into the first architecture and most expensive when retrofitted after the first enterprise contract demands it. That mistake has a dedicated article: why most medical startups misread ISO 13485.
Direct Answer
The most common remote patient monitoring compliance failures are structural rather than technical: a privacy commitment with no procedure behind it, suppliers evaluated once and never re-evaluated, consent flows that never entered design control, management reviews that never discuss data handling, certified systems left to decay between surveillance audits, and early-stage companies deferring the work until an enterprise contract forces it. Organizations typically report that the technical work was competent — what failed was the system's ability to demonstrate that remote patient monitoring compliance is controlled and repeatable.
The Build
Building Remote Patient Monitoring Compliance Into a Management System That Holds
Sequence. Structure. Sustain.
The organizations that will get remote patient monitoring compliance right are not the ones with the best security team. They are the ones whose management system was already load-bearing before connected health arrived. A strong system absorbs a new discipline the way a good foundation absorbs a new floor. A weak one buckles, and the crack shows up somewhere nobody was looking.
The sequence that works for remote patient monitoring compliance is unglamorous. Score where your quality system actually stands using MSI's self-scoring ISO 13485 Gap Analysis, which covers every clause and returns a readiness percentage with a recommended next step for each item. Map every data-handling activity you already perform to the clause that governs it. Find the activities with no owner, no procedure, or no record, because those are your real exposure. Write the procedures with the engineers who will follow them rather than handing down a template they will quietly ignore. Train the people. Then audit it internally before a registrar, an investigator, or a health system's security team does it for you.
That last step is the one most organizations skip and the one that pays for itself fastest in remote patient monitoring compliance. Building genuine internal audit capability is not a nice-to-have in a connected health company; it is the difference between owning your management system and renting it. Where the documented system and daily reality have drifted apart, an independent operational assessment such as The Portrait is often the fastest way to see the actual distance. And where spreadsheets stop scaling, our guide to procedure-first ISO compliance automation covers how to sequence the platform decision without automating a broken process.
This is the terrain where experienced ISO consulting earns its keep. Translating a technical discipline into clause-mapped, auditable procedure is not a security skill and it is not an engineering skill — it is a management systems skill. Management Systems International (MSI) has spent 28 years doing exactly that translation in regulated environments where evidence has to survive contact with an investigator: 80+ certifications supported, 200+ audits attended, and 600+ professionals trained across manufacturing, technology, medical device, government, healthcare, and other regulated industries. ISO consulting for a connected health company is not about handing over a binder. It is about leaving behind a system your team can run without you.
Three things distinguish MSI's approach to remote patient monitoring compliance. MSI writes the actual procedures alongside your engineers rather than issuing templates, which is decisive in design controls where a generic procedure is worse than none. MSI trains your staff to run internal audits, because a company that depends permanently on an external auditor has not built a system. And MSI attends the certification audit — being in the room on audit day is a commitment most consultants will not make, and it is where 200+ audits of pattern recognition actually gets spent. If you are still orienting to the landscape, our primer on what ISO standards actually are and our piece on why ISO certification matters commercially are the right starting points. For continuity-minded readers, our discussion of ISO's role in operational continuity covers how these systems behave under disruption.
Your Next Step
Map Your Patient Data Evidence to Clauses — Before a Health System's Security Team Does It for You
Bring your data flow diagram, your supplier list, and your consent screens to a planning session with MSI. In one working conversation you will leave with a clause-by-clause map of where each piece of evidence lives in your management system, an honest list of what has no procedure behind it yet, and a sequence for fixing it — what to do first, what can wait, and what a realistic timeline looks like given the staff you actually have. MSI has attended 200+ certification audits and knows which controls a registrar tests hardest.
Call 760-434-9141 to book a planning session.
Want a score before you call? Run the self-scoring ISO 13485 Gap Analysis — every clause of the standard, an instant readiness percentage, and a recommended next step for each item. Bring the scored results and you skip straight to sequencing.
Need the system built, not just mapped? SurePath builds a QMSR-ready ISO 13485 quality system around how your team actually designs and ships — and MSI is in the room on audit day. Already certified? SureResults keeps the system audit-ready year-round, which is the only realistic way to stop remote patient monitoring compliance from decaying between surveillance visits.
Need the supplier control written today? The Purchasing and Supplier Procedure Template builds Clause 7.4 end to end — evaluation criteria, approved supplier list, re-evaluation triggers, purchasing information, verification, and records. It is the single highest-leverage procedure in remote patient monitoring compliance, because 7.4 is where the drift starts.
Need the whole team operating to the documented system? The ISO 13485 QMS Overview course gets everyone speaking the same clause language before the auditor arrives.
Still deciding whether to commit? Watch the ISO Executive Decision Briefs — short leadership videos on what an ISO program really costs, how long it takes, and what it returns, so you can make the call with numbers instead of guesses.
Questions
Remote Patient Monitoring Compliance: Frequently Asked Questions
Ask. Answer. Act.
Does HIPAA cover my fitness tracker or monitoring app?
Usually not. HIPAA applies to covered entities and their business associates. A direct-to-consumer wearable typically sits outside that structure, which is why Oura's own policy states it is generally not a Covered Entity for its consumer services and that records you direct into the service no longer fall under HIPAA while held there. Where a vendor operates under a Business Associate Agreement with a health system, HIPAA does apply to that arrangement. Ask which of the two you are in — the answer changes everything downstream.
Is SOC 2 enough for remote patient monitoring compliance?
It is meaningful and it is not sufficient on its own for remote patient monitoring compliance. A Type II report attests that selected controls operated over a defined past period. It does not certify a management system with a defined scope, a Statement of Applicability, internal audit, management review, and annual surveillance. Many buyers now ask for both, and increasingly ask which one governs when the two disagree.
Should we wait for the new HIPAA Security Rule before investing?
No. Final action has moved to a long-term agenda targeting July 2027 and could shift again, be narrowed, or be withdrawn. The existing Security Rule remains fully enforceable, OCR has extended enforcement attention from risk analysis to risk management, and buyers are applying their own standards now. Most of the proposed measures describe what reasonable security looks like regardless of rulemaking. The delay is runway, not relief.
Does MSI implement ISO/IEC 27001?
No, and we would rather say so plainly than blur it. MSI implements ISO 9001, ISO 13485, ISO 14001, and ISO 45001, with an expanding focus on ISO 7101 healthcare quality. What MSI builds is the management system foundation — document control, competence, internal audit, management review, corrective action, supplier control — that an information security management system plugs into cleanly. If you need an ISMS implemented, engage a specialist; if you need the architecture that keeps every standard honest, that is our work.
Our monitoring product is a wellness device, not a regulated one. Does any of this apply?
The device regulation may not apply. The remote patient monitoring compliance trust question absolutely does, and so does contract law, state privacy law, and consumer protection enforcement — as the Flo record demonstrates. A wellness classification changes which regulator is interested. It does not change whether a hospital procurement team will buy from you, and it does not change what a jury thinks of an unreadable consent flow.
How long does it take to get remote patient monitoring compliance evidence in order?
It depends on what already exists. Organizations typically report that mapping current activities to clauses takes weeks, while writing and implementing the missing procedures and training people to follow them takes months. Companies with a mature quality system and immature data governance move faster than the reverse, because procedure discipline is harder to install than a technical habit. Call 760-434-9141 for a timeline based on your actual staffing.
Who owns this internally — security, quality, or legal?
All three, and the seam is where remote patient monitoring compliance is won or lost. Security performs the technical work. Legal writes the commitments. The management system makes both provable through defined procedures, competent people, controlled records, design review, change control, corrective action, and management review. Assign the activity, assign the evidence, and name one person accountable for the boundary between them.
Related Reading
Keep Going
Medical Device Cybersecurity — the companion piece: how February 2026 moved security evidence inside the quality system.
Digital Health FDA Compliance — is your wearable a regulated device or a general wellness product?
The FDA QMSR Rule — how 21 CFR Part 820 and ISO 13485 became one regulation.
ISO 13485 Management Review — the Clause 5.6.2 inputs, and where data governance now belongs among them.
CAPA Under ISO 13485 — why a fix is not a corrective action.
ISO 13485 Gap Analysis — score every clause yourself and get an instant readiness percentage.
ISO 7101 Healthcare Quality — the first international standard for healthcare quality management.
Multi-Site ISO Integration — how specialized standards plug into one architecture.
ISO Consulting Services — what MSI actually does, and how engagements are structured.
ISO Certified Suppliers — why supplier certification changes your own risk profile.
Purchasing and Supplier Procedure Template — build Clause 7.4 supplier control end to end, clause-mapped and editable.
Five ISO Maintenance Risks — how certified systems quietly decay between audits.
ISO Benefits for Government Entities — data-heavy public sector organizations and management system discipline.
References & Further Reading
Federal Register. HIPAA Security Rule To Strengthen the Cybersecurity of Electronic Protected Health Information (NPRM, January 6, 2025).
U.S. HHS Office for Civil Rights. HIPAA Security Rule NPRM fact sheet.
U.S. HHS. The HIPAA Security Rule.
U.S. FTC. Fertility-tracking app developer settles FTC allegations (January 2021).
U.S. FTC. FTC finalizes order with Flo Health (June 2021).
U.S. FTC. Flo Health, Inc. case file.
Federal Register. Flo Health, Inc.; Analysis of Proposed Consent Order.
Oura Health Oy. Security Center and Privacy Policy.
ISO. ISO/IEC 27001 — Information security management systems.
ISO. ISO/IEC 27002 — Information security controls.
ISO. ISO 13485:2016 — Medical devices quality management systems.
ISO. ISO 14971:2019 — Risk management for medical devices.
eCFR. 21 CFR Part 820 — Quality Management System Regulation.
Federal Register. Medical Devices; Quality System Regulation Amendments — 89 FR 7496.
U.S. FDA. Cybersecurity in Medical Devices (final guidance).
U.S. FDA. General Wellness: Policy for Low Risk Devices.
U.S. FDA. Digital Health Center of Excellence — Cybersecurity.
Global ACI. Accreditation and conformity assessment arrangements.
NIST. Cybersecurity Framework.
CISA. Advisories and coordinated disclosure.
AAMI. Association for the Advancement of Medical Instrumentation.
IMDRF. International Medical Device Regulators Forum.
ASQ. Quality auditing resources.
About the Author
About Management Systems International (MSI)
Diana Lynn is President and Principal ISO Consultant at Management Systems International (MSI), a veteran-owned, female-owned ISO consulting firm she co-founded in 1998. With 28 years of experience including extensive AS9100 work in MSI's early years, MSI's track record includes 80+ certifications supported, 200+ audits attended, and 600+ professionals trained across manufacturing, technology, medical device, government, healthcare, and other regulated industries.
Today MSI implements ISO 9001, ISO 13485, ISO 14001, and ISO 45001, with an expanding focus on ISO 7101 healthcare quality.
msi-international.com · 760-434-9141
